India, March 18 -- Mankind Pharma has acquired the brand Rivotril from Roche for the Indian market, with exclusive rights to manufacture, market and distribute the product across the country.

Rivotril is the innovator/ reference brand of clonazepam and is widely prescribed for the management of neurological and psychiatric conditions. Often regarded as a Textbook brand in its category with a strong clinical legacy, Rivotril further strengthens Mankind Pharma's presence in the central nervous system (CNS) therapy segment and complements its existing neuro portfolio.

The acquisition builds on Mankind Pharma's growing focus on chronic therapies, where the company has steadily expanded its presence through new launches, in-licensing partner...